Details for New Drug Application (NDA): 208943
✉ Email this page to a colleague
The generic ingredient in CORPHEDRA is ephedrine sulfate. There are sixty-eight drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the ephedrine sulfate profile page.
Summary for 208943
Tradename: | CORPHEDRA |
Applicant: | Endo Operations |
Ingredient: | ephedrine sulfate |
Patents: | 0 |
Pharmacology for NDA: 208943
Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Agonists |
Physiological Effect | Increased Norepinephrine Activity |
Medical Subject Heading (MeSH) Categories for 208943
Suppliers and Packaging for NDA: 208943
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CORPHEDRA | ephedrine sulfate | SOLUTION;INTRAVENOUS | 208943 | NDA | Endo USA, Inc. | 42023-216 | 42023-216-83 | 25 VIAL in 1 CARTON (42023-216-83) / 1 mL in 1 VIAL |
CORPHEDRA | ephedrine sulfate | SOLUTION;INTRAVENOUS | 208943 | NDA | Endo USA, Inc. | 42023-216 | 42023-216-25 | 25 VIAL in 1 CARTON (42023-216-25) / 1 mL in 1 VIAL (42023-216-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 50MG/ML (50MG/ML) | ||||
Approval Date: | Jan 27, 2017 | TE: | AP | RLD: | No |
Complete Access Available with Subscription